Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2026 ▲▼ | Q2 2026 ▲▼ | Change ▲▼ | Q1 2026 ▲▼ | Q2 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Praxis Precision Medicines, Inc.(PRAX) | 885,500 | 640,000 | -245,500 | $285.30M | $214.27M | 10.98% | -$71.03M |
| BridgeBio Oncology Therapeutics, Inc.(BBOT) | 17,878,594 | 17,878,594 | 0 | $160.01M | $136.23M | 6.98% | -$23.78M |
| Parabilis Medicines Inc | 0 | 4,615,612 | +4,615,612 | $0 | $126.33M | 6.47% | +$126.33M |
| Rapport Therapeutics, Inc.(RAPP) | 2,957,521 | 2,657,521 | -300,000 | $92.54M | $110.74M | 5.67% | +$18.20M |
| Erasca, Inc.(ERAS) | 5,800,000 | 6,000,000 | +200,000 | $93.84M | $109.92M | 5.63% | +$16.08M |
| Edgewise Therapeutics, Inc.(EWTX) | 3,260,000 | 2,510,000 | -750,000 | $102.69M | $101.98M | 5.23% | -$708.7K |
| EyePoint, Inc.(EYPT) | 8,265,000 | 7,000,000 | -1,265,000 | $106.54M | $100.10M | 5.13% | -$6.44M |
| Alumis Inc | 3,949,241 | 3,285,596 | -663,645 | $87.00M | $92.46M | 4.74% | +$5.45M |
| ABIVAX Société AnonymeADS(ABVX) | 760,000 | 675,000 | -85,000 | $84.63M | $89.95M | 4.61% | +$5.32M |
| Dianthus Therapeutics, Inc.(DNTH) | 950,000 | 750,000 | -200,000 | $79.72M | $73.11M | 3.75% | -$6.61M |
| Bright Minds Biosciences Inc.(DRUG) | 1,059,331 | 900,000 | -159,331 | $77.30M | $63.18M | 3.24% | -$14.12M |
| MoonLake ImmunotherapeuticsCL A(MLTX) | 4,480,433 | 3,205,433 | -1,275,000 | $83.52M | $62.41M | 3.20% | -$21.11M |
| BioAge Labs, Inc.(BIOA) | 2,890,605 | 2,390,605 | -500,000 | $50.56M | $58.59M | 3.00% | +$8.04M |
| Oruka Therapeutics, Inc.(ORKA) | 533,340 | 533,340 | 0 | $26.16M | $50.76M | 2.60% | +$24.60M |
| Adlai Nortye Group Ltd.ADS(ANL) | 2,897,857 | 3,978,229 | +1,080,372 | $20.05M | $45.75M | 2.34% | +$25.70M |
| BridgeBio Pharma, Inc.(BBIO) | 850,000 | 550,000 | -300,000 | $63.12M | $40.96M | 2.10% | -$22.16M |
| Tango Therapeutics, Inc.(TNGX) | 1,425,000 | 1,300,000 | -125,000 | $29.81M | $40.64M | 2.08% | +$10.83M |
| Biohaven Ltd.(BHVN) | 1,760,000 | 2,610,000 | +850,000 | $14.89M | $38.84M | 1.99% | +$23.95M |
| AgomAb Therapeutics NVADS(AGMB) | 2,465,348 | 2,465,348 | 0 | $25.86M | $32.00M | 1.64% | +$6.14M |
| MBX Biosciences, Inc.(MBX) | 1,120,000 | 550,000 | -570,000 | $33.43M | $30.36M | 1.56% | -$3.07M |
| Climb Bio, Inc.(CLYM) | 0 | 2,106,000 | +2,106,000 | $0 | $27.46M | 1.41% | +$27.46M |
| Olema Pharmaceuticals, Inc.(OLMA) | 3,900,000 | 2,150,000 | -1,750,000 | $58.15M | $26.90M | 1.38% | -$31.25M |
| Damora Therapeutics, Inc.(DMRA) | 1,525,000 | 1,000,000 | -525,000 | $39.50M | $26.01M | 1.33% | -$13.49M |
| Pharvaris N V COM | 1,000,000 | 750,000 | -250,000 | $28.25M | $25.93M | 1.33% | -$2.31M |
| Corbus Pharmaceuticals Holdings, Inc.(CRBP) | 2,344,971 | 2,344,971 | 0 | $22.02M | $22.00M | 1.13% | -$23.4K |
| Spyre Therapeutics, Inc.(SYRE) | 0 | 225,000 | +225,000 | $0 | $19.98M | 1.02% | +$19.98M |
| Definium Therapeutics, Inc.(DFTX) | 0 | 400,000 | +400,000 | $0 | $18.82M | 0.96% | +$18.82M |
| Newamsterdam Pharma Company ORDINARY SHARES | 950,000 | 500,000 | -450,000 | $30.41M | $16.95M | 0.87% | -$13.46M |
| Roivant Sciences Ltd.SHS(ROIV) | 750,000 | 475,000 | -275,000 | $20.77M | $16.81M | 0.86% | -$3.96M |
| Cabaletta Bio, Inc.(CABA) | 5,500,000 | 5,000,000 | -500,000 | $14.79M | $15.55M | 0.80% | +$755.0K |
| Helix Acquisition Corp. IIICL A(HLXC) | 1,297,500 | 1,297,500 | 0 | $13.18M | $13.81M | 0.71% | +$622.8K |
| Ascendis Pharma A/S(ASND) | 0 | 50,000 | +50,000 | $0 | $13.34M | 0.68% | +$13.34M |
| Kailera Therapeutics Inc | 0 | 550,000 | +550,000 | $0 | $12.12M | 0.62% | +$12.12M |
| Insmed Incorporated(INSM) | 190,000 | 75,000 | -115,000 | $31.07M | $8.00M | 0.41% | -$23.07M |
| Faeth Therapeutics, Inc.(FTH) | 306,222 | 1,028,242 | +722,020 | $9.65M | $7.66M | 0.39% | -$2.00M |
| Enliven Therapeutics Inc | 0 | 150,000 | +150,000 | $0 | $7.61M | 0.39% | +$7.61M |
| Tarsus Pharmaceuticals, Inc.(TARS) | 225,000 | 100,000 | -125,000 | $15.78M | $6.29M | 0.32% | -$9.49M |
| iBio, Inc.(IBIO) | 0 | 3,570,000 | +3,570,000 | $0 | $6.25M | 0.32% | +$6.25M |
| Crinetics Pharmaceuticals In | 250,000 | 125,000 | -125,000 | $9.08M | $4.68M | 0.24% | -$4.40M |
| Arcutis Biotherapeutics, Inc.(ARQT) | 450,000 | 175,000 | -275,000 | $10.60M | $4.59M | 0.24% | -$6.01M |
| Arrowhead Pharmaceuticals, Inc.(ARWR) | 100,000 | 50,000 | -50,000 | $6.27M | $4.08M | 0.21% | -$2.19M |
| Structure Therapeutics IncADS | 175,000 | 75,000 | -100,000 | $8.44M | $4.03M | 0.21% | -$4.41M |
| Research Alliance Corp IiiCL A | 0 | 370,000 | +370,000 | $0 | $3.96M | 0.20% | +$3.96M |
| Cogent Biosciences, Inc.(COGT) | 200,000 | 100,000 | -100,000 | $7.70M | $3.87M | 0.20% | -$3.83M |
| Altimmune, Inc.(ALT) | 0 | 1,250,000 | +1,250,000 | $0 | $3.80M | 0.19% | +$3.80M |
| Amylyx Pharmaceuticals, Inc.(AMLX) | 350,000 | 200,000 | -150,000 | $4.87M | $3.59M | 0.18% | -$1.27M |
| Odyssey Therapeutics Inc | 0 | 175,000 | +175,000 | $0 | $3.27M | 0.17% | +$3.27M |
| Vaxcyte, Inc.(PCVX) | 100,000 | 50,000 | -50,000 | $5.81M | $2.91M | 0.15% | -$2.90M |
| Boundless Bio, Inc.(BOLD) | 0 | 1,000,000 | +1,000,000 | $0 | $2.50M | 0.13% | +$2.50M |
| Quince Therapeutics Inc | 0 | 5,498 | +5,498 | $0 | $100.0K | 0.01% | +$100.0K |
| Ascendis Pharma A/SADR(ASND) | 95,000 | 0 | -95,000 | $21.73M | $0 | — | -$21.73M |
| Axsome Therapeutics, Inc.(AXSM) | 50,000 | 0 | -50,000 | $8.45M | $0 | — | -$8.45M |
| Centessa Pharmaceuticals PlcADS | 1,050,000 | 0 | -1,050,000 | $41.71M | $0 | — | -$41.71M |
| Context Therapeutics Inc.(CNTX) | 529,550 | 0 | -529,550 | $1.39M | $0 | — | -$1.39M |
| Maze Therapeutics, Inc.(MAZE) | 750,000 | 0 | -750,000 | $22.39M | $0 | — | -$22.39M |
| Monte Rosa Therapeutics, Inc.(GLUE) | 400,000 | 0 | -400,000 | $6.58M | $0 | — | -$6.58M |
| Rallybio Corporation(RLYB) | 400,000 | 0 | -400,000 | $3.59M | $0 | — | -$3.59M |
| Terns Pharmaceuticals Inc | 300,000 | 0 | -300,000 | $15.82M | $0 | — | -$15.82M |
| Zura Bio LimitedCL A(ZURA) | 1,450,000 | 0 | -1,450,000 | $8.63M | $0 | — | -$8.63M |